Introduction
Dendritic cells (DCs) are potent professional antigen presenting cells. They play a crucial role in innate and adaptive immune responses [1] [2] [3] . In fact, DCs recognize, acquire, process, and present antigens to native and resting T cells for induction of an antigen-specific immune response. Because DCs presenting tumor-associated antigens (TAAs) can activate TAA-specific immune response, many researchers have been attracted to TAA-presenting DCs as a vaccine for cancer immunotherapy [4, 5] . A key for vaccine production is delivery of TAA into DCs. The most extensively studied approach for TAA-loading of DCs is to expose them to defined antigenic proteins or the entire contents of tumor cells. Antigenic proteins are internalized via endocytosis and degraded to peptide fragments. These peptides are presented by binding to major histocompatibility complex (MHC) class II molecules, which mainly activate CD4+ T cells, thereby inducing humoral immunity. Nevertheless, these vaccines have not been useful for cancer immunotherapy to date, because fragmented antigen peptides do not necessarily bind to MHC class II molecules efficiently because of the MHC molecules' 5 diversity [6] .
Another promising strategy for supplying DCs with TAA is the delivery of TAA-coded DNA or mRNA to express TAA in DCs as an endogenous antigen. The TAAs expressed in DCs are degraded by proteasomes after ubiquitination. These fragmented peptides are presented by binding to MHC class I molecules, which mainly activate CD8+ T cells to induce cellular immunity. Antigen peptides processed from endogenous proteins bind efficiently to MHC molecules. Reportedly, some cancer cells present their own TAA on the surface via MHC class I molecules for recognition by CD8+ T cells. Therefore, the preparation of TAA-loading DCs by gene delivery can induce antitumor immune responses in a practical manner, constituting a powerful tool for cancer immunotherapy [5, 7] .
Attempts have been made to develop efficient vectors for DCs from adenovirus [8, 9] . Although the transfection efficiency of a conventional adenovirus is not high, toward DCs, Okada et al. achieved efficient transfection of 90% DC2.4 cells using the fiber-mutant adenoviral vector [8] , indicating that modification of adenovirus might engender production of efficient vectors for DCs. However, adenoviruses induced not 6 only gene transfer, but also dispensable immune responses [10] . Consequently, non-viral vectors have been attractive for gene delivery into DCs because of their low immunogenicity and lack of pathogenicity, even though they have lower transfection activity than virus-based vectors.
Recent progress in the area of non-viral vector-mediated gene delivery has revealed various cellular processes that are involved in the vector-mediated transfection of cells. They include cellular binding and subsequent internalization, transfer from endosome into cytosol (endosomal escape), nuclear entry, and gene transcription [11, 12] . Therefore, to achieve efficient transfection of DCs, vectors must be rationally designed specifically for DC to pass through these cellular processes efficiently. Among these cellular processes, efficient cellular binding and endosomal escape greatly affect the efficiency of non-viral vector-mediated transfection [11] [12] [13] .
Previously, we prepared hybrid complexes comprising lipoplexes and liposomes modified with pH-sensitive fusogenic polymers, such as succinylated poly(glycidol) (SucPG) and 3-methylglutarylated poly(glycidol) (MGluPG) [14] [15] [16] [17] . These complexes, which are designated respectively as SucPG complex and MGluPG complex, generate 7 fusion capability under mildly acidic conditions. In addition, these complexes have a structure in which the positively charged lipoplexes are covered with negatively charged polymer-modified liposomes. Consequently, once an appropriate ligand, such as transferrin, was conjugated, they achieved efficient transfection of various cancer-derived cell lines, such as HeLa and K562 cells, through efficient cellular association via receptor-mediated endocytosis and through endosomal escape via membrane fusion with endosome ( Fig. 1 ) [14] [15] [16] [17] .
To advance the development of potent vectors that are designed specifically for DCs based on the hybrid complexes consisting of pH-sensitive fusogenic liposomes and lipoplexes, we attempted to optimize their structure from the viewpoints of ligand and pH-sensitive properties, which would contribute to high cellular uptake and efficient endosomal escape, respectively, using DC2.4 cells, a murine DC line, as a model of DCs. Our results demonstrated that the structural optimization of the complexes was able to produce an efficient non-viral vector for DCs.
Materials & Methods

Materials
SucPG and MGluPG were synthesized according to our reports [18, 19] .
SucPG and MGluPG with the composition (x:y:z, Fig. 1 ) of 18:74:8 and 9:81:10 (mol/mol/mol), respectively. TRX-20 ( Fig. 2a) [20] and L-dioleoyl phosphatidyl-ethanolamine (DOPE) were provided from Terumo corp. and NOF corp., respectively. Dilauroyl phosphatidyl choline (DLPC) and transferrin were purchased by Aldrich. Aminoethylcarbamylmethyl mannan (Fig. 2b ) was synthesized as follows [21] . carbodiimide hydrochloride (EDC, Dojindo) on ice for 1 day. The reaction mixture was purified by dialysis, and then lyophilized. The amounts of amino groups were detected by fluorescamine assay [22] , by which an amino group per 22 units was estimated ( 
Preparation of pH-sensitive polymer-modified liposome-lipoplex complexes
Lipoplexes were prepared as reported previously [16] . Plasmid DNA, pCMV-Luc or pEGFP-C1, in 5% glucose solution was added to lipid film including TRX-20, DLPC and DOPE at the ratio of 1/1/2 (mol/mol/mol), and they were incubated for 10 min on ice. SucPG or MGluPG-modified liposomes were prepared by suspending a mixture of SucPG or MGluPG and EYPC in 5 mM Hepes solution containing 5% glucose (pH 7.4) and subsequent extrusion through a polycarbonate membrane with a pore size of 50 nm.
Transferrin or aminoethylcarbamylmethyl mannan was conjugated to SucPG or MGluPG using EDC as previously reported [14] . Briefly, to the liposome suspension was added EDC (0. Then, transfected cells were evaluated by luciferase assay [14] .
For GFP expression, the complexes or the lipoplexes containing pEGFP-C1 (0.75 µg) were added gently to the DC2.4 cells (1.5 × 10 5 cells) incubated for 2 days in a 12-well plate. After 4 h-incubation at 37 °C, the cells were washed with HBBS three times, followed by the incubation in culture medium at 37 °C for 24 h. Then, GFP-transfected cells were evaluated using flowcytometer [16] . SuperFect (QIAGEN) and Lipofetamine2000 (Invitrogen) were also used according to the manufacturer's instructions.
Cellular uptake
The DC2.4 cells (1 × 10 5 cells) cultured for 2 days in a 12-well plate were washed with HBBS and then incubated in culture medium. The complexes or the lipoplexes containing plasmid DNA (1 µg), in which DOPE was substituted by NBD-PE (3 mol%), were added gently to the cells and incubated for 4 h at 37 °C. The cells were washed with HBBS three times, and then flowcytometerical analysis of detached cells using trypsin was performed [16] . For inhibition assay, free transferrin, mannan or dextran sulfate at different concentrations was preincubated to cell for an hour before the incubation of these complexes labeled with NBD-PE.
Microscopic analysis
The DC2. 
Cytotoxicity
The cytotoxicity of the lipoplexes and the SucPG and MGluPG complexes was assessed by WST-8 assay [24] . The cells were treated with the complexes for 4 h and incubated for 40 h according to the transfection procedures. Then, the culture medium was carefully replaced with 0.11 ml of fresh RPMI containing 10% FCS and 10 μl of WST-8 (5 mg/ml) was added to each well. After 2 h-incubation at 37 °C, the survived cells was determined by absorbance at 450 nm using Wallac 1420 ARVO SX multilabel counter (Perkin Elmer Life Sciences).
MHC class I presentation
Surface marker expression was analyzed according to the previous report [8] . cells as for cancer cells [14] [15] [16] [17] . The following assay was performed using lipoplexes
and SucPG complexes at the N/P ratio of 4.
Ligand effect on transfection of DC2.4 cells
The SucPG complexes with transferrin exhibited higher transfection activities than the intact lipoplexes (Fig. 3) . Although DCs have transferrin receptors, mannose receptors are known to be largely expressed in DCs. Mannan, as a ligand for mannose receptors, was used for delivery to DCs [10, [25] [26] [27] . Therefore, mannan was incorporated to the SucPG complexes to increase their transfection activity. Mannan derivatives with amino groups were synthesized [21] and bound to carboxyl groups of SucPG using a condensation reagent, as in the method of attachment of transferrin to the complexes [14] [15] [16] [17] . Figure 4 shows that the transfection activities of both the complexes bearing transferrin and mannan were unexpectedly almost equivalent over a wide range of carboxylated unit/nucleotide unit ratios. In addition, the complex without ligands also exhibited activity at the same level. This figure indicates that ligands such as transferrin and mannan were not effective to improve transfection activity of SucPG complexes to DC2.4 cells.
Complexation of plain SucPG-modified liposomes with the lipoplex also tends to increase the transfection activity (Fig. 4) . Our previous study showed that their complexation resulted in significant reduction of the transfection activity toward HeLa cells because of reduction of affinity to cell [14, 16] . These facts imply that the negatively charged surface derived from the SucPG-modified liposomes might not suppress interaction between the complex and DCs.
We next investigated the cellular association of SucPG complexes to elucidate the ligand effect. Figure 5a shows that the amount of plain SucPG complex associated to DCs was almost equal to those of ligand-bearing complexes and was equal to that of the parent lipoplex. Our previous studies showed that the SucPG complexes without transferrin to HeLa cells exhibited a much lower level of association to HeLa cells than the parent lipoplex because the positively charged surface of the lipoplex was shielded by negatively charged polymer-modified liposomes [14, 16] . Indeed, the SucPG complexes without ligand showed lower association to the cells than those with ligand.
Therefore, Figure 5a suggests that the negatively charged liposomes of the complex might be involved in its association to DC2.4 cells.
Inhibition assay was also performed using free transferrin and free mannan (Fig.   5b ), which indicates that neither free transferrin nor free mannan inhibited the association of these complexes. This result further confirms that transferrin and mannan in the complexes only slightly affected association of the complexes to DC2.4 cells.
It is known that DCs engulf microorganisms or apoptotic cells with an anionic
component via scavenger receptors [28] . Considering that SucPG complexes contain negatively charged moieties derived from SucPG-modified liposomes, involvement of scavenger receptors is possible. Therefore, we also examined inhibitory effects of dextran sulfate, which has been used as an inhibitor of interaction between negatively 19 charged compounds and scavenger receptors [29] . Figure 5b shows that the addition of dextran sulfate strongly suppressed cellular association of the SucPG complexes, depending on the concentration. Consequently, the SucPG complexes were likely to have been internalized mainly via scavenger receptors. In fact, enhanced uptake by macrophages through scavenger receptors was also reported for poly(acrylic acid)-coated liposomes [29] .
Although we conjugated mannan and transferrin to the complexes, they only slightly affected their association to the cells. Instead, the complexes were taken up efficiently by DC2.4 cells through interaction with scavenger receptors, which bind to anionic molecules [30] . In fact, DCs are known to have many kinds of scavenger receptors [30] . Therefore, multivalent binding between these receptors and many carboxylate anions of the polymer chains fixed on the complexes might cause their strong interaction, resulting in the highly efficient association of the complexes to DCs.
Effect of pH-sensitive fusogenic polymers on transfection activity of complexes
We next examined the endosomal escape to improve transfection activities.
Recently, another type of pH-sensitive complex, MGluPG complexes, in which SucPG is substituted by MGluPG (Fig. 1) , was prepared. The MGluPG was synthesized by the reaction of poly(glycidol) with 3-methyl glutaric anhydride [19] . This polymer has more hydrophobic side groups than SucPG and was therefore more fusogenic than SucPG [19] . In addition, the MGluPG complexes exhibited greater fusion ability under mildly acidic conditions than the SucPG complexes because of the stronger fusion activity of MGluPG [17] .
We transfected DC2.4 cells with MGluPG complexes containing EGFP gene.
First, the transfection condition of the complexes was optimized using MGluPG liposomes. The SucPG complexes at N/P ratios of 4 exhibited the most efficient transfection (Fig. 3) . Therefore, we prepared the MGluPG complexes at the same N/P ratio with varying ratios of carboxylated unit of MGluPG liposomes to the DNA nucleotide unit of the lipoplex. Figure 6a shows that the complexation of MGluPG liposomes improved the transfection activity of the parent lipoplex. In addition, the MGluPG complex with the carboxylated unit/nucleotide unit ratio of 2 exhibited the highest transfection activity. At that ratio, 25% of GFP-expressed cells were observed.
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Transfection activities of the complexes with optimal composition were compared to those of commercially available reagents, such as Lipofectamine2000 and SuperFect.
Fluorescence intensity of EGFP for the transfected cells was detected using flowcytometry (Fig. 6b) . 
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The cytotoxicity of the complexes was also examined using WST-8 assay [24] and compared to that of the parent lipoplex. The survived cells after transfection with the SucPG and MGluPG complexes and the lipoplex were estimated respectively as 50%, 54%, and 39%. Although these complexes exhibited some toxicity to DC2.4 cells during the cellular treatment, their cytotoxicity was still lower than that of the parent lipoplex. It is likely that, for the complexes, the negatively charged liposomes shielded positively charged surface of the lipoplex, resulting in the lower toxicity for these complexes than for the lipoplex.
Mechanism of the efficient transfection activity by the MGluPG complexes
We examined the cell association and the intracellular localization of this complex to elucidate the cause of the high activity of the MGluPG complex. Figure 7A shows We also examined the subcellular distribution of these complexes containing FITC-labeled DNA in DC2.4 cells, in which the acidic compartments were stained using LysoTracker. Figure 7B shows that many yellow dots were observed by treatment with lipoplexes, indicating that the lipoplexes were localized dominantly at acidic compartments such as endosomes/lysosomes. In cells treated with the SucPG or MGluPG complex, green fluorescence was also observed at different locations from those of the red dots, which suggests that the SucPG and MGluPG complexes were able to escape from endosomal compartments. No large difference was found in the intracellular localization of the complexes. Indeed, it might be difficult to identify small differences in amounts of DNA existing in the cytosol using this technique. We observed that the MGluPG complex had about three-times-higher ability to induce membrane fusion than the SucPG complex at around pH 5-4.5, as judged by fluorescence resonance energy transfer assay using fluorescent lipids [17] . Such a high fusion ability of MGluPG complexes might strongly promote the transfer of plasmid DNA from endosomes to cytosol, resulting in the high transfection activities to DC2.4 cells.
Toward application to immunotherapy
We showed that SucPG and MGluPG complexes efficiently induced expression of whether the MHC class I is specific for transgene. We will examine that issue using more appropriate genes, such as ovalbumin gene, as well as their ability to induce MHC class I, which has target-specificity.
Conclusion
In this study, we prepared hybrid complexes of lipoplex and pH-sensitive 
